Background: Matrix metalloproteinases (MMPs) gene polymorphisms contribute to the risk of developing cardiovascular diseases. This study aimed to determine the possible association of two polymorphisms of two MMP genes (MMP1 and MMP3) with essential hypertension (EH) in a Burkinabè population. Method: The genomic DNA of 72 hypertensive patients and 73 normotensive patients was extracted from their blood samples by the Salting Out technique. The ？1607 1G/2G MMP1, ？1171 5A/6A MMP3 polymorphisms were detected by the allele-specific polymerase chain reaction technique. Results: The chi-squared test shows that an association exists between frequencies of alleles 1G (OR = 1.93; p = 0.012) and 5A (OR = 1.9; p = 0.013); genotypes 1G1G (p = 0.007) and 5A5A (p = 0.0001) and EH in the study population. So, the frequencies of the combined 1G1G/5A5A and 2G2G/6A6A genotypes were higher in cases (p = 0.0068). Multinomial logistic regression found that HDL cholesterol (OR = 38.27; p = 0.011), blood glucose (OR = 2. 46; p = 0.009), family history of hypertension (OR = 6.88; p = 0.03), lack of exercise (OR = 23.85; p = 0.008), were independent risk factors for developing essential hypertension in our general study population. Conclusion: Our study suggests that genetic polymorphism in MMP1 and MMP3 might be helpful in determining susceptibility to EH in Burkinabè patients. In addition, susceptibility to EH might be related to MMP1 and MMP3 gene expression, which affect its plasma levels.
References
[1]
World Health Organization (2012) World Health Statistics 2012. World Health Organization. https://iris.who.int/handle/10665/44857
[2]
World Health Organization (2023) Global Report on Hypertension: The Race against a Silent Killer. https://www.who.int/publications/i/item/9789240081062
[3]
Mills, K.T., Bundy, J.D., Kelly, T.N., Reed, J.E., Kearney, P.M., Reynolds, K., et al. (2016) Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies From 90 Countries. Circulation, 134, 441-450. https://doi.org/10.1161/circulationaha.115.018912
[4]
Mills, K.T., Stefanescu, A. and He, J. (2020) The Global Epidemiology of Hypertension. Nature Reviews Nephrology, 16, 223-237. https://doi.org/10.1038/s41581-019-0244-2
[5]
Hendriks, M.E., Wit, F.W.N.M., Roos, M.T.L., Brewster, L.M., Akande, T.M., de Beer, I.H., et al. (2012) Hypertension in Sub-Saharan Africa: Cross-Sectional Surveys in Four Rural and Urban Communities. PLOS ONE, 7, e32638. https://doi.org/10.1371/journal.pone.0032638
[6]
Soubeiga, J.K., Millogo, T., Bicaba, B.W., Doulougou, B. and Kouanda, S. (2017) Prevalence and Factors Associated with Hypertension in Burkina Faso: A Countrywide Cross-Sectional Study. BMC Public Health, 17, Article No. 64. https://doi.org/10.1186/s12889-016-3926-8
[7]
Ali, M.A.M., Cho, W.J., Hudson, B., Kassiri, Z., Granzier, H. and Schulz, R. (2010) Titin Is a Target of Matrix Metalloproteinase-2: Implications in Myocardial Ischemia/Reperfusion Injury. Circulation, 122, 2039-2047. https://doi.org/10.1161/circulationaha.109.930222
[8]
Nagase, H., Visse, R. and Murphy, G. (2006) Structure and Function of Matrix Metalloproteinases and TIMPs. Cardiovascular Research, 69, 562-573. https://doi.org/10.1016/j.cardiores.2005.12.002
[9]
Djuric, T., Kuveljic, J., Djordjevic, A., Dekleva, M., Stankovic, G., Stankovic, A., et al. (2022) Association of MMP1 and MMP3 Haplotypes with Myocardial Infarction and Echocardiographic Parameters of the Left Ventricle. Molecular Genetics & Genomic Medicine, 10, e2022. https://doi.org/10.1002/mgg3.2022
[10]
Huang, R., Deng, L., Shen, A., Liu, J., Ren, H. and Xu, D. (2013) Associations of MMP1, 3, 9 and TIMP3 Genes Polymorphism with Isolated Systolic Hypertension in Chinese Han Population. International Journal of Medical Sciences, 10, 840-847. https://doi.org/10.7150/ijms.5728
[11]
Rutter, J.L. et al. (1998) A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Creates an ETS Binding Site and Augments Transcription. Cancer Research, 58, 5321-5325.
[12]
de Almeida Belo, V., Parente, J.M., Tanus-Santos, J.E. and Castro, M.M. (2016) Matrix Metalloproteinase (MMP)-2 Decreases Calponin-1 Levels and Contributes to Arterial Remodeling in Early Hypertension. Biochemical Pharmacology, 118, 50-58. https://doi.org/10.1016/j.bcp.2016.08.012
[13]
Sirugo, G., Hennig, B.J., Adeyemo, A.A., Matimba, A., Newport, M.J., Ibrahim, M.E., et al. (2008) Genetic Studies of African Populations: An Overview on Disease Susceptibility and Response to Vaccines and Therapeutics. Human Genetics, 123, 557-598. https://doi.org/10.1007/s00439-008-0511-y
[14]
Miller, S.A., Dykes, D.D. and Polesky, H.F. (1988) A Simple Salting Out Procedure for Extracting DNA from Human Nucleated Cells. Nucleic Acids Research, 16, 1215-1215. https://doi.org/10.1093/nar/16.3.1215
[15]
Morosova, E.B., Chukhlovin, A.B., Kulagina, N.V., Kipich, N.V. and Totolian, A.A. (2012) Functional Gene Polymorphism of Matrix Metalloproteinase-1 Is Associated with Benign Hyperplasia of Myo-and Endometrium in the Russian Population. Genetic Testing and Molecular Biomarkers, 16, 1032-1037. https://doi.org/10.1089/gtmb.2011.0376
[16]
Yamada, Y., Matsui, K., Takeuchi, I., Oguri, M. and Fujimaki, T. (2015) Association of Genetic Variants with Hypertension in a Longitudinal Population-Based Genetic Epidemiological Study. International Journal of Molecular Medicine, 35, 1189-1198. https://doi.org/10.3892/ijmm.2015.2151
[17]
Wang, X., Xu, X., Su, S. and Snieder, H. (2015) Familial Aggregation and Childhood Blood Pressure. Current Hypertension Reports, 17, Article No. 509. https://doi.org/10.1007/s11906-014-0509-x
[18]
Levine, R.S., Hennekens, C.H., Perry, A., Cassady, J., Gelband, H. and Jesse, M.J. (1982) Genetic Variance of Blood Pressure Levels in Infant Twins. American Journal of Epidemiology, 116, 759-764. https://doi.org/10.1093/oxfordjournals.aje.a113465
[19]
Lifton, R.P. (1996) Molecular Genetics of Human Blood Pressure Variation. Science, 272, 676-680. https://doi.org/10.1126/science.272.5262.676
[20]
Souslova, V., Townsend, P.A., Mann, J., van der Loos, C.M., Motterle, A., D’Acquisto, F., et al. (2010) Allele-Specific Regulation of Matrix Metalloproteinase-3 Gene by Transcription Factor NFκB. PLOS ONE, 5, e9902. https://doi.org/10.1371/journal.pone.0009902
[21]
Sakowicz, A., Lisowska, M., Biesiada, L., Rybak-Krzyszkowska, M., Gach, A., Sakowicz, B., et al. (2018) Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia. Disease Markers, 2018, Article 1371425. https://doi.org/10.1155/2018/1371425
[22]
Qintao, C., Yan, L., Changhong, D., Xiaoliang, G. and Xiaochen, L. (2014) Genetic Polymorphism of Matrix Metalloproteinase-1 and Coronary Artery Disease Susceptibility: A Case-Control Study in a Han Chinese Population. Genetic Testing and Molecular Biomarkers, 18, 826-831. https://doi.org/10.1089/gtmb.2014.0222
[23]
Saratzis, A., Bown, M.J., Wild, B., Nightingale, P., Smith, J., Johnson, C., et al. (2015) Association between Seven Single Nucleotide Polymorphisms Involved in Inflammation and Proteolysis and Abdominal Aortic Aneurysm. Journal of Vascular Surgery, 61, 1120-1128.E1. https://doi.org/10.1016/j.jvs.2013.11.099
[24]
Institut National de la Statistique et de la Démographie (2022) Cinquième recensement général de la population et de l’habitation du burkina faso. Institut National de la Statistique et de la Démographie. https://www.insd.bf/fr/file-download/download/public/2073
[25]
Tchelougou, D., Kologo, J.K., Karou, S.D., Yaméogo, V.N., Bisseye, C., Djigma, F.W., et al. (2015) Renin-Angiotensin System Genes Polymorphisms and Essential Hypertension in Burkina Faso, West Africa. International Journal of Hypertension, 2015, Article 979631. https://doi.org/10.1155/2015/979631
[26]
Kaess, B.M., Rong, J., Larson, M.G., Hamburg, N.M., Vita, J.A., Levy, D., et al. (2012) Aortic Stiffness, Blood Pressure Progression, and Incident Hypertension. JAMA, 308, Article 875. https://doi.org/10.1001/2012.jama.10503
[27]
Kim, H. and Kim, S. (2019) Pulse Wave Velocity in Atherosclerosis. Frontiers in Cardiovascular Medicine, 6, Article 41. https://doi.org/10.3389/fcvm.2019.00041
[28]
Renna, N.F., de las Heras, N. and Miatello, R.M. (2013) Pathophysiology of Vascular Remodeling in Hypertension. International Journal of Hypertension, 2013, Article 808353. https://doi.org/10.1155/2013/808353
[29]
Takase, H., Dohi, Y., Toriyama, T., Okado, T., Tanaka, S., Sonoda, H., et al. (2011) Brachial-Ankle Pulse Wave Velocity Predicts Increase in Blood Pressure and Onset of Hypertension. American Journal of Hypertension, 24, 667-673. https://doi.org/10.1038/ajh.2011.19
[30]
Geronooz, I. and Krzesinski, J.M. (2000) Obesity and Hypertension: From Physiopathology to Treatment. Revue Médicale de Liège, 55, 921-928.
[31]
Murthy, G.V.S., Fox, S., Sivasubramaniam, S., Gilbert, C.E., Mahdi, A.M., Imam, A.U., et al. (2013) Prevalence and Risk Factors for Hypertension and Association with Ethnicity in Nigeria: Results from a National Survey: Cardiovascular Topics. Cardiovascular Journal of Africa, 24, 344-350. https://doi.org/10.5830/cvja-2013-058
[32]
Doulougou, B., Kouanda, S., Rossier, C., Soura, A. and Zunzunegui, M.V. (2014) Differences in Hypertension between Informal and Formal Areas of Ouagadougou, a Sub-Saharan African City. BMC Public Health, 14, Article No. 893. https://doi.org/10.1186/1471-2458-14-893
[33]
Ahn, S. and Gupta, C. (2018) Genetic Programming of Hypertension. Frontiers in Pediatrics, 5, Article 285. https://doi.org/10.3389/fped.2017.00285
[34]
Munroe, P.B., Barnes, M.R. and Caulfield, M.J. (2013) Advances in Blood Pressure Genomics. Circulation Research, 112, 1365-1379. https://doi.org/10.1161/circresaha.112.300387
[35]
Yayehd, K., Damorou, F., Akakpo, R., Tchérou, T., N’Da, N.W., Pessinaba, S., et al. (2013) Prévalence de l’hypertension artérielle et description de ses facteurs de risque à Lomé (Togo): Résultats d’un dépistage réalisé dans la population générale en mai 2011. Annales de Cardiologie et d’Angéiologie, 62, 43-50. https://doi.org/10.1016/j.ancard.2012.09.006
[36]
Chen, J., Li, R., Geng, T., Wang, Y., Lu, Q., Tu, Z., et al. (2023) Differences in HDL-Related Mortality Risk between Individuals with and without Hypertension: A Prospective Cohort Study in UK Biobank. European Journal of Preventive Cardiology, 30, 951-959. https://doi.org/10.1093/eurjpc/zwad053
[37]
von Eckardstein, A., Nordestgaard, B.G., Remaley, A.T. and Catapano, A.L. (2023) High-Density Lipoprotein Revisited: Biological Functions and Clinical Relevance. European Heart Journal, 44, 1394-1407. https://doi.org/10.1093/eurheartj/ehac605
[38]
Cheng, Y., Kao, W.L., Mitchell, B.D., O’Connell, J.R., Shen, H., McArdle, P.F., et al. (2009) Genome-Wide Association Scan Identifies Variants near Matrix Metalloproteinase (MMP) Genes on Chromosome 11q21-22 Strongly Associated with Serum MMP-1 Levels. Circulation: Cardiovascular Genetics, 2, 329-337. https://doi.org/10.1161/circgenetics.108.834986
[39]
Bisogni, V., Cerasari, A., Pucci, G. and Vaudo, G. (2020) Matrix Metalloproteinases and Hypertension-Mediated Organ Damage: Current Insights. Integrated Blood Pressure Control, 13, 157-169. https://doi.org/10.2147/ibpc.s223341
[40]
de Jaeger, C. and Cherin, P. (2012) Matrice extracellulaire, physiologie et vieillissement vasculaire. Médecine & Longévité, 4, 41-53. https://doi.org/10.1016/j.mlong.2012.02.002
[41]
Letra, A., Zhao, M., Silva, R.M., Vieira, A.R. and Hecht, J.T. (2014) Functional Significance of MMP3 and TIMP2 Polymorphisms in Cleft Lip/Palate. Journal of Dental Research, 93, 651-656. https://doi.org/10.1177/0022034514534444
